EUVIMEDEUVIMED entdecken
Crossref

Ivabradine, Heart Failure and Chronic Kidney Disease

Luca Di Lullo, Antonio Bellasi, Domenico Russo, Mario Cozzolino, Claudio Ronco, Alberto Santoboni, Giovanni Barbera

Nephrology @ Point of Care · 2015

DOI: 10.5301/poc.5000190 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nephrology @ Point of Care, 2015. Verfasst von Luca Di Lullo und 6 weiteren Autor:innen. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 29 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The incidence and prevalence of congestive heart failure are actually increasing worldwide, especially in Western countries. In Europe and the United States, congestive heart failure represents a disabling clinical disease, accountable for increased hospitalization and health care costs. European guidelines have underlined the importance of pharmacological treatment to improve both patients' outcomes and quality of life. The latest clinical trials to evaluate ivabradine's efficacy have underlined its usefulness as a stand-alone medication and in combination with conventional congestive heart failure therapy, including in chronic kidney disease patients.

Zitieren

APA

Lullo, L. D., Bellasi, A., Russo, D., Cozzolino, M., Ronco, C., Santoboni, A., & Barbera, G. (2015). Ivabradine, Heart Failure and Chronic Kidney Disease. Nephrology @ Point of Care. https://doi.org/10.5301/poc.5000190

Vancouver

Lullo LD, Bellasi A, Russo D, Cozzolino M, Ronco C, Santoboni A, et al. Ivabradine, Heart Failure and Chronic Kidney Disease. Nephrology @ Point of Care. 2015. doi:10.5301/poc.5000190

BibTeX
@article{Lullo2015,
  author = {Lullo, Luca Di and Bellasi, Antonio and Russo, Domenico and Cozzolino, Mario and Ronco, Claudio and Santoboni, Alberto and Barbera, Giovanni},
  title = {Ivabradine, Heart Failure and Chronic Kidney Disease},
  journal = {Nephrology @ Point of Care},
  year = {2015},
  doi = {10.5301/poc.5000190}
}
Kostenlos starten →